NYSE · FUL

H. B. Fuller Company

$56.53 +$0.83 (+1.49%) 1D Pre-market

Key Metrics

$3.00B
Market cap
16.13×
P/E · TTM
Revenue · TTM
$185.74M
Net income
EPS · TTM $3.36
Dividend yield 1.7%
Free cash flow $140.77M
Beta · 1Y 0.98
EBITDA · TTM
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 20
    2 insider transaction filings hit the record.

    Form 4s are events, not verdicts — officers, directors, and 10% owners reporting their own trades. The forms post hours before the media writes them up.

    RECEIPT: SEC FORM 4 × 2, TIMESTAMPED
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 20.3 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Apr 8
    The stock moved +8.7% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Apr 8
  • Mar 20
    From its Feb 13 high, the share price fell 27%.

    Peak close $67.49 on Feb 13; trough close $49.29 on Mar 20. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -27%

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$3.00B
Enterprise value$4.95B
Shares outstanding53.8M
52-wk range$48.71 – $68.63
Avg volume · 20D384.8K
Net cash −$1.96B
Book value / share$37.66
IndustryAdhesives & Sealants
ExchangeNYSE
About H. B. Fuller Company
IPO dateJun 1, 1972
Employees7100

H.B. Fuller Co manufactures and sells adhesives, sealants, and other chemical-based products. The company organizes itself into three segments: Hygiene, Health and Consumable Adhesives, Engineering Adhesives, and Construction Adhesives.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E16.13
P/S
P/FCF21.28
EV/EBITDA
EV/Sales
Graham №$53.36

Profitability

Gross
Operating
Net
FCF
ROE / ROIC 9.5% · —

Financial Health

Current ratio1.80
Quick ratio1.12
Debt / equity1.00
Debt / EBITDA
Net cash −$1.96B
Working capital$620.36M

Cash Flow · TTM

Operating CF $322.89M
Capex −$182.12M
Free cash flow $140.77M
Buybacks $48.82M
Dividends paid $51.38M
Shareholder yield 3.3%

Piotroski F-Score

5 / 9
Middling fundamentals · 5 of 9 signals passing

Altman Z-Score

Insufficient balance-sheet inputs

Graham Number vs Price

$53.36 vs $56.53
Trades 1.1× above classic defensive value — priced for growth
Fundamentals through 2026-05-30 · computed by TickerWolf from SEC filings